Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Morris

Showing results (731-740 of 767) with videos related to

Pageof 77
Sort By:
JCO Precision Oncology|November 20, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid TumorsRouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyLarry J Copeland, Mark F Brady, Robert A Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancerManu Prasad, Alex T Cheng, Marcel Mayer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
Cell|October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabNadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Science (New York, N.Y.)|January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agentJ Linnen, J Wages, Z Y Zhang-Keck, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Head & Neck|December 19, 2018
American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodulesCharles J Meltzer, Jonathan Irish, Peter Angelos, et al.
Pageof 77

Showing results (731-740 of 767) with videos related to

Sort By:
Pageof 77
JCO Precision Oncology|November 20, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid TumorsRouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyLarry J Copeland, Mark F Brady, Robert A Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancerManu Prasad, Alex T Cheng, Marcel Mayer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
Cell|October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabNadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Science (New York, N.Y.)|January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agentJ Linnen, J Wages, Z Y Zhang-Keck, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Head & Neck|December 19, 2018
American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodulesCharles J Meltzer, Jonathan Irish, Peter Angelos, et al.
Pageof 77